Bristol Myers Squib confirms new CFO
Posted by admin in Career Ladder on Mon, 12/04/2010 - 15:47
Bristol-Myers Squibb Co's has formalised the appointment of Charles Bancroft as CFO.
Bancroft has been serving as acting CFO since the start of this year. He becomes the full-time occupant of the role vacated by Jean-Marc Hulet on December 31st 2010, taking responsibility for the direction and management of the company's fiscal operations.
He will report to Lamberto Andreotti, the company's chief operating officer who is set to become chief executive officer next month. "His tenure with Bristol-Myers Squibb has been marked by strong leadership and depth of experience in finance, earning him trust and respect from his peers,” said Andreotti.
"The Board of Directors and I have great confidence in Charlie's ability to provide the financial stewardship needed to help drive shareholder value.His tenure with Bristol-Myers Squibb has been marked by strong leadership and depth of experience in finance, earning him trust and respect from his peers across all functions and within the entire finance organisation."
Bancroft has held various positions within the finance organisation, including international assignments, senior leadership positions in the global pharmaceutical business and also with ConvaTec. He received a B.S. in Accounting from Drexel University, his M.B.A. in Finance from Temple University and is a certified public accountant.
The Bottom Line:If Mr Cable has his way...
"If Mr Cable had his way, all the big banks would be broken up and bonuses would be virtually eliminated - a sure-fire way in my view of guaranteeing an end to the UK’s ability to compete as an international financial centre. Let’s not forget that this is a man who is on record as saying that everyone who works in a bank has an ‘aristocratic lifestyle’ clearly demonstrating his lack of understanding of the sector." A tough line on bankers’ bonuses could make a brain drain of financial talent a distinct possibility, warns Paul Marsden. Read more